Paracetamol in every dosage form — tablets, syrup, injection, suppository, effervescent — plus ibuprofen, aspirin and diclofenac.
Fever and pain are the most common reasons patients anywhere in the world reach for a medicine. Artemisine Medicines Technology is one of the few suppliers that controls the whole paracetamol value chain — 5,000 tons per year of paracetamol API (DML No. Jin20160069) feeding our own finished-dosage lines, which means stable supply, stable cost and full batch traceability.
Our paracetamol family covers every clinical scenario: 500 mg tablets and effervescent tablets for adults, syrups and oral suspensions for children, suppositories for vomiting patients, and paracetamol injection for hospital IV use. The NSAID range adds ibuprofen tablets and suspension, aspirin 300 mg and diclofenac sodium in tablets, injection and suppository forms for musculoskeletal and inflammatory pain.
All antipyretic-analgesic products are manufactured in China-GMP workshops and released to BP / enterprise standards with complete COA, COPP, DMF and CTD documentation — ready for OTC registration and pharmacy-channel distribution in more than 50 countries.
All products are GMP manufactured and supplied with COA, COPP, DMF and CTD dossiers. Tap any product for specifications and WHO prescribing guidance.
Tell us your target market and annual volume — our export team replies within 24 hours.
Tablets 500 mg, effervescent tablets, syrups and oral solutions, pediatric suspensions, suppositories 150 mg, and paracetamol injection 500 mg/5 mL — all from our own 5,000 t/yr API plant.
Yes. Artemisine holds DML No. Jin20160069 for paracetamol API with 5,000 tons annual capacity, available with COA and DMF for formulation manufacturers.
Ibuprofen (tablets, suspension, suppository), aspirin 300 mg tablets, and diclofenac sodium (tablets 50 mg, injection 75 mg/3 mL) — covering both OTC and prescription analgesic segments.
Artemisine Medicines